Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Catch up on the day's biggest business stories
Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Sign up for Axios NW Arkansas
Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters
U.S. Secretary of Veterans Affairs Robert Wilkie. Photo: Steven Ferdman/Getty Images
Veterans Affairs Secretary Robert Wilkie said in a letter on Wednesday that veterans are being treated for the novel coronavirus with hydroxychloroquine only when patients and their doctors find it medically necessary.
Why it matters: The Food and Drug Administration warned doctors last week about prescribing the antimalarial drug to COVID-19 patients as it appears to be causing some serious and potentially life-threatening side effects.
- An independent analysis of veterans hospitalized at VA facilities, which has not yet been peer-reviewed, found an increased risk of death associated with coronavirus patients who were only treated with the antimalarial drug.
- The study is the largest examination to date of how the drug interacts with coronavirus patients, AP reports.
Details: The analysis, conducted by university researchers with VA approval, retrospectively looked through medical records of 368 male veterans, with a median age of 58, who were hospitalized with COVID-19 March 11 to April 11, per the study and Wilkie's letter.
What they're saying: "The Veterans who received hydroxychloroquine were at highest risk prior to receiving the medication," Wilkie wrote on Wednesday, adding that the VA is adhering to FDA guidance for the drug's use.
- Wilkie declined to say in a call with major veterans organizations on Wednesday whether the agency had issued guidance to patients and doctors on the use of hydroxychloroquine, as well as how widely the drug is used, AP reports.
- The VA told AP that it "permits use of the drug after ensuring veterans and caretakers are aware of potential risks associated with it, as we do with any other drug or treatment.”
Go deeper: States stockpile hydroxychloroquine for coronavirus as FDA issues warning